Colorectal cancer: Targeting BRAF mutations equally?
- PMID: 26552951
- DOI: 10.1038/nrclinonc.2015.190
Colorectal cancer: Targeting BRAF mutations equally?
Comment on
-
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.J Clin Oncol. 2015 Dec 1;33(34):4032-8. doi: 10.1200/JCO.2015.63.2497. Epub 2015 Oct 12. J Clin Oncol. 2015. PMID: 26460303 Free PMC article. Clinical Trial.
References
-
- J Clin Oncol. 2015 Dec 1;33(34):4032-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials